Effect of CEP-751 (KT-6587) on neuroblastoma xenografts expressing TrkB

Audrey E. Evans(Purdue University West Lafayette), Garrett M. Brodeur(Children's Hospital of Philadelphia), Naohiko Ikegaki(University of Illinois Chicago), Xou Liu(Children's Hospital of Philadelphia), Kristin D. Kisselbach(Teva Pharmaceuticals (Czechia)), Craig A. Dionne, Angelica Eggert(Children's Hospital of Philadelphia), Anne M. Camoratto
Medical and Pediatric Oncology
January 1, 2001
10.1002/1096-911x(20010101)36:1<181::aid-mpo1043>3.0.co;2-q
Cited by 62

Related Papers

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
|Journal of Clinical Oncology|1993|2.3k
A proposed staging for children with neuroblastoma.Children's cancer study group A
|Cancer|1971|953
Treatment of Wilms' tumor. Results of the third national Wilms' tumor study
|Cancer|1989|685
International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma.
|Journal of Clinical Oncology|1988|608
The treatment of medulloblastoma
|Journal of neurosurgery|1990|583